Biocon Limited
Government Pension Fund Global (Norway) bought 6,500,02 shares of Biocon Limited for ₹25.03 Cr at ₹385.00 apiece in a block deal on September 9, 2026.
A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.
Norway's sovereign wealth fund, managed by Norges Bank Investment Management. World's largest SWF with over USD 2 trillion in assets, invested across 8,700+ companies globally including Indian equities.